Overview

Efficacy of Naltrexone Treatment as Augmentation to SSRI in OCD Patients

Status:
Completed
Trial end date:
2004-12-01
Target enrollment:
Participant gender:
Summary
Assessing the efficacy of Naltrexone as augmentation to SSRI in patients with OCD
Phase:
N/A
Details
Lead Sponsor:
Sheba Medical Center
Treatments:
Naltrexone